Heart failure remains a leading global killer, with South Asia facing unique challenges in left ventricular systolic dysfunction management. Punjab has a high-risk population with prevalent modifiable risk factors. Limited local data exists on combined clinical/biochemical survival predictors.
The aim of the study was to estimate death rates due to heart failure for patients who were admitted to Institute of Cardiology and Allied hospital Faisalabad-Pakistan during April-December (2015) and to Develop an integrated risk model with clinical/lab variables including ejection fraction, serum markers, and comorbidities.
Characteristic | alive N = 2031 |
dead N = 961 |
Test Statistic2 | p-value2 |
---|---|---|---|---|
BP | 1.9 | 0.17 | ||
No | 137 / 203 (67%) | 57 / 96 (59%) | ||
Yes | 66 / 203 (33%) | 39 / 96 (41%) | ||
platelets_cat | 3.5 | 0.17 | ||
< Q1 | 61 / 203 (30%) | 39 / 96 (41%) | ||
< Q2 | 73 / 203 (36%) | 27 / 96 (28%) | ||
< Q3 | 69 / 203 (34%) | 30 / 96 (31%) | ||
EFraction_cat | 32 | <0.001 | ||
30-45 | 115 / 203 (57%) | 31 / 96 (32%) | ||
EF<=30 | 42 / 203 (21%) | 51 / 96 (53%) | ||
EF>45 | 46 / 203 (23%) | 14 / 96 (15%) | ||
1 n / N (%) | ||||
2 Pearson’s Chi-squared test |
Characteristic | alive N = 2031 |
dead N = 961 |
Test Statistic2 | p-value2 |
---|---|---|---|---|
Diabetes | 0.00 | 0.97 | ||
No | 118 / 203 (58%) | 56 / 96 (58%) | ||
Yes | 85 / 203 (42%) | 40 / 96 (42%) | ||
Anaemia | 1.3 | 0.25 | ||
No | 120 / 203 (59%) | 50 / 96 (52%) | ||
Yes | 83 / 203 (41%) | 46 / 96 (48%) | ||
Gender | 0.01 | 0.94 | ||
F | 71 / 203 (35%) | 34 / 96 (35%) | ||
M | 132 / 203 (65%) | 62 / 96 (65%) | ||
Smoking | 0.05 | 0.83 | ||
No | 137 / 203 (67%) | 66 / 96 (69%) | ||
Yes | 66 / 203 (33%) | 30 / 96 (31%) | ||
1 n / N (%) | ||||
2 Pearson’s Chi-squared test |
Characteristic | alive N = 2031 |
dead N = 961 |
Test Statistic2 | p-value2 |
---|---|---|---|---|
Age | 59 (11) | 65 (13) | -4.2 | <0.001 |
Sodium | 137.2 (4.0) | 135.4 (5.0) | 3.2 | 0.002 |
Creatinine | 1.18 (0.65) | 1.84 (1.47) | -4.2 | <0.001 |
Ejection.Fraction | 40 (11) | 33 (13) | 4.6 | <0.001 |
Pletelets | 266,657 (97,531) | 256,381 (98,526) | 0.84 | 0.40 |
CPK | 540 (754) | 670 (1,317) | -0.90 | 0.37 |
1 Mean (SD) | ||||
2 Welch Two Sample t-test |
Unadjusted
|
Adjusted
|
||||||
---|---|---|---|---|---|---|---|
Characteristic | N | HR | 95% CI | p-value | HR | 95% CI | p-value |
platelets_cat | 299 | ||||||
< Q1 | — | — | — | — | |||
< Q2 | 0.70 | 0.43, 1.14 | 0.15 | 0.64 | 0.38, 1.08 | 0.091 | |
< Q3 | 0.79 | 0.49, 1.27 | 0.3 | 0.78 | 0.47, 1.29 | 0.3 | |
Gender | 299 | ||||||
F | — | — | — | — | |||
M | 1.01 | 0.67, 1.54 | >0.9 | 0.77 | 0.48, 1.26 | 0.3 | |
Age | 299 | 1.04 | 1.03, 1.06 | <0.001 | 1.05 | 1.03, 1.07 | <0.001 |
EFraction_cat | 299 | ||||||
30-45 | — | — | — | — | |||
EF<=30 | 3.18 | 2.03, 4.97 | <0.001 | 3.46 | 2.16, 5.55 | <0.001 | |
EF>45 | 1.30 | 0.69, 2.44 | 0.4 | 1.22 | 0.64, 2.33 | 0.5 | |
Smoking | 299 | ||||||
No | — | — | — | — | |||
Yes | 0.99 | 0.64, 1.53 | >0.9 | 1.09 | 0.67, 1.77 | 0.7 | |
Sodium | 299 | 0.93 | 0.90, 0.97 | <0.001 | 0.93 | 0.89, 0.97 | 0.001 |
BP | 299 | ||||||
No | — | — | — | — | |||
Yes | 1.55 | 1.03, 2.33 | 0.037 | 1.73 | 1.13, 2.66 | 0.012 | |
Diabetes | 299 | ||||||
No | — | — | — | — | |||
Yes | 0.96 | 0.64, 1.44 | 0.8 | 1.08 | 0.70, 1.65 | 0.7 | |
Anaemia | 299 | ||||||
No | — | — | — | — | |||
Yes | 1.40 | 0.94, 2.09 | 0.10 | 1.33 | 0.86, 2.06 | 0.2 | |
CPK | 299 | 1.00 | 1.00, 1.00 | 0.3 | 1.00 | 1.00, 1.00 | 0.006 |
Abbreviations: CI = Confidence Interval, HR = Hazard Ratio |
The statistical analysis identified age, Ejection fraction, sodium and BP as the significant variables affecting the likelihood of mortality among heart failure patients. Both these variables were observed to be associated with an increased hazard of death. The findings that seem surprising are non-significance of smoking and diabetes. However, similar results concerning diabetes and smoking have been reported in other studies as well. The reason behind may be smoking and diabetes are basically causes of heart problem at initial stages. We were only concerned with patients of NYHA class III and IV which are advanced stages of heart failure. Up to these stages, these factors (diabetes and smoking) may probably be controlled by medications and hence these factors do not have significant effect on deaths due to heart failure in class III and IV.
Performance of model was checked using Akaike Information Criterion ,Bayesian Information Criterion and residuals such as coxsnell , deviance and martingale residuals and all these suggest that our final model fits the data pretty well.